Tag Archives: biotech


Sofinnova Partners Closed Its Crossover II Fund at €725 Million, Above Target, to Back Late-Stage European Life Sciences Companies:

Sofinnova Partners, the Paris-, London- and Milan-based life sciences venture firm, announced on November 16 the final close of Sofinnova Crossover II at €725 million ($815 million… Continue reading →

Enveda Raised $311 Million Series E at a $2 Billion Valuation:

HedgeCo.Net — AI-native drug discovery company Enveda closed a $311 million Series E on September 23, 2026 at a $2 billion valuation led by Catalio Capital Management, according to… Continue reading →

Biotech Rallies: Composite Models Take Advantage

New York (HedgeCo.net)  – The biotech sector has been on an incredible run over the last four years and so far in 2015, the rally has continued. In the last four years, the iShares Nasdaq Biotechnology ETF (NYSE: IBB) has gone […]